Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000294744 | SCV000372059 | benign | Peroxisome biogenesis disorder 8A (Zellweger) | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV000549075 | SCV000638111 | benign | Peroxisome biogenesis disorder | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676059 | SCV001813398 | likely benign | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676059 | SCV005224243 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676059 | SCV000801793 | likely benign | not provided | 2017-10-03 | no assertion criteria provided | clinical testing | |
Genome |
RCV000845059 | SCV000986900 | not provided | Peroxisome biogenesis disorder 8A (Zellweger); Peroxisome biogenesis disorder 8B | no assertion provided | phenotyping only | Variant interpretted as Likely benign and reported on 10/30/2014 by GTR ID 320384. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |